Butantan-DV Dengue Vaccine Clinical Trials, Dosage, Indication, News, Side Effects
Butantan Institute's single-dose, tetravalent, live, attenuated Butantan-DV Dengue Vaccine is conducting phase 3 clinical trials as of August 2024. Butantan-DV, the... Read more...